Product Description
Vitamin C (ascorbic acid) is a nutrient your body needs to form blood vessels, cartilage, muscle and collagen in bones. Vitamin C is also vital to your body's healing process. (Sourced from: https://www.mayoclinic.org/drugs-supplements-vitamin-c/art-20363932)
Mechanisms of Action: Prolyl Hydroxylase Cofactor,Free Radical Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral,Intravenous
FDA Designation: None *
Approval Status: Approved
Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam
Approved Indications: Vitamin D Deficiency | Vitamin D Deficiency | Vitamin D Deficiency
Known Adverse Events: Diplopia | Dizziness | Headache | Erythema | Pruritus | Anaphylaxis | Angioedema | Urticaria | Edema
Company: Norgine
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: China, Germany, Korea, Netherlands, Spain, United States
Active Clinical Trial Count: 16
Highest Development Phases
Phase 3: Acute Respiratory Distress Syndrome|Coronavirus Infections|Pneumonia|Sepsis
Phase 2: Adenocarcinoma|Cardiac Arrest|Cerebellar Ataxia|Colorectal Cancer|Herpes Zoster|Lung Cancer|Lymphoma|Pancreatic Cancer|Prostate Cancer|Stem Cell Transplant|Tachycardia, Ventricular|Vaginosis, Bacterial|Ventricular Fibrillation
Phase 1: Anemia|Brain Cancer|Intermittent Claudication|Peripheral Arterial Disease|Peripheral Vascular Diseases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| J21127 | P2 |
Recruiting |
Prostate Cancer |
2028-03-01 |
|
| FSJD-EnergiQ-2023 | P2 |
Unknown Status |
Cerebellar Ataxia |
2028-01-01 |
|
| The ACCURATE Study | P2 |
Unknown Status |
Unknown |
2026-12-31 |
|
| PACMAN 2.1 | P2 |
Active, not recruiting |
Adenocarcinoma|Pancreatic Cancer |
2025-12-31 |